Notch signaling is associated with ALDH activity and an aggressive metastatic phenotype in murine osteosarcoma cells

Frontiers in Oncology

Volumn 3 JUN, Issue , 2013, Pages

  Mu, Xiaodong ^a   Isaac, Christian ^a,b   Greco, Nicholas ^a,b   Huard, Johnny ^a,b   Weiss, Kurt ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

ALDH; Metastasis; Mouse osteosarcoma cells; Notch; Osteosarcoma

Indexed keywords

ALDEHYDE DEHYDROGENASE; BONE MORPHOGENETIC PROTEIN 2; JAGGED1; NOTCH RECEPTOR; VASCULOTROPIN;

ANIMAL CELL; ARTICLE; CELL INVASION; CELL MIGRATION ASSAY; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVITY; FLUORESCENCE ACTIVATED CELL SORTING; GENE; GENE ACTIVATION; METASTASIS; MOUSE; NONHUMAN; NOTCH GENE; OSTEOSARCOMA; OSTEOSARCOMA CELL; OXIDATIVE STRESS; PHENOTYPE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WOUND HEALING;

EID: 84891613866     PISSN: None     EISSN: 2234943X     Source Type: Journal    
DOI: 10.3389/fonc.2013.00143     Document Type: Article

References (43)

1. Artavanis-Tsakonas, S., Rand, M. D., and Lake, R. J. (1999). Notch signaling: cell fate control and signal integration in development. Science 284, 770-776. doi:10.1126/science.284.5415.770.
2. Bielack, S. S., Kempf-Bielack, B., Delling, G., Exner, G. U., Flege, S., Helmke, K., et al. (2002). Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J. Clin. Oncol. 20, 776-790. doi:10.1200/JCO.20.3.776.
3. Borggrefe, T., and Oswald, F. (2009). The Notch signaling pathway: transcriptional regulation at Notch target genes. Cell. Mol. Life Sci. 66, 1631-1646. doi:10.1007/s00018-009-8668-7.
4. Bray, S. J. (2006). Notch signalling: a simple pathway becomes complex. Nat. Rev. Mol. Cell Biol. 7, 678-689. doi:10.1038/nrm2009.
5. Carrle, D., and Bielack, S. S. (2006). Current strategies of chemotherapy in osteosarcoma. Int. Orthop. 30, 445-451. doi:10.1007/s00264-006-0192-x.
6. Charafe-Jauffret, E., Ginestier, C., Iovino, F., Tarpin, C., Diebel, M., Esterni, B., et al. (2010). Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer. Clin. Cancer Res. 16, 45-55. doi:10.1158/1078-0432.CCR-09-1630.
7. Cheung, A. M., Wan, T. S., Leung, J. C., Chan, L. Y., Huang, H., Kwong, Y. L., et al. (2007). Aldehyde dehydrogenase activity in leukemic blasts defines a subgroup of acute myeloid leukemia with adverse prognosis and superior NOD/SCID engrafting potential. Leukemia 21, 1423-1430. doi:10.1038/sj.leu.2404721.
8. Cho, H. J., Lee, T. S., Park, J. B., Park, K. K., Choe, J. Y., Sin, D. I., et al. (2007). Disulfiram suppresses invasive ability of osteosarcoma cells via the inhibition of MMP-2 and MMP-9 expression. J. Biochem. Mol. Biol. 40, 1069-1076. doi:10.5483/BMBRep.2007.40.6.1069.
9. Engin, F., Yao, Z., Yang, T., Zhou, G., Bertin, T., Jiang, M. M., et al. (2008). Dimorphic effects of Notch signaling in bone homeostasis. Nat. Med. 14, 299-305. doi:10.1038/nm1712.
10. Ferrari, S., Smeland, S., Mercuri, M., Bertoni, F., Longhi, A., Ruggieri, P., et al. (2005). Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups. J. Clin. Oncol. 23, 8845-8852. doi:10.1200/JCO.2004.00.5785.
11. Geling, A., Steiner, H., Willem, M., Bally-Cuif, L., and Haass, C. (2002). A gamma-secretase inhibitor blocks Notch signaling in vivo and causes a severe neurogenic phenotype in zebrafish. EMBO Rep. 3, 688-694. doi:10.1093/embo-reports/kvf124.
12. Gibbs, C. P. Jr., Levings, P. P., and Ghivizzani, S. C. (2011). Evidence for the osteosarcoma stem cell. Curr. Orthop. Pract. 22, 322-326. doi:10.1097/BCO.0b013e318221aee8.
13. Hayden, J. B., and Hoang, B. H. (2006). Osteosarcoma: basic science and clinical implications. Orthop. Clin. North Am. 37, 1-7. doi:10.1016/j.ocl.2005.06.004.
14. Hilton, M. J., Tu, X., Wu, X., Bai, S., Zhao, H., Kobayashi, T., et al. (2008). Notch signaling maintains bone marrow mesenchymal progenitors by suppressing osteoblast differentiation. Nat. Med. 14, 306-314. doi:10.1038/nm1716.
15. Honoki, K., Fujii, H., Kubo, A., Kido, A., Mori, T., Tanaka, Y., et al. (2010). Possible involvement of stem-like populations with elevated ALDH1 in sarcomas for chemotherapeutic drug resistance. Oncol. Rep. 24, 501-505. doi:10.3892/or_00000885.
16. Hu, Y. Y., Zheng, M. H., Zhang, R., Liang, Y. M., and Han, H. (2012). Notch signaling pathway and cancer metastasis. Adv. Exp. Med. Biol. 727, 186-198. doi:10.1007/978-1-4614-0899-4_14.
17. Huang, E. H., Hynes, M. J., Zhang, T., Ginestier, C., Dontu, G., Appelman, H., et al. (2009). Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis. Cancer Res. 69, 3382-3389. doi:10.1158/0008-5472.CAN-08-4418.
18. Kamakura, S., Oishi, K., Yoshimatsu, T., Nakafuku, M., Masuyama, N., and Gotoh, Y. (2004). Hes binding to STAT3 mediates crosstalk between Notch and JAK-STAT signalling. Nat. Cell Biol. 6, 547-554. doi:10.1038/ncb1138.
19. Khanna, C., Prehn, J., Yeung, C., Caylor, J., Tsokos, M., and Helman, L. (2000). An orthotopic model of murine osteosarcoma with clonally related variants differing in pulmonary metastatic potential. Clin. Exp. Metastasis 18, 261-271. doi:10.1023/A:1006767007547.
20. Klinakis, A., Szabolcs, M., Politi, K., Kiaris, H., Artavanis-Tsakonas, S., and Efstratiadis, A. (2006). Myc is a Notch1 transcriptional target and a requisite for Notch1-induced mammary tumorigenesis in mice. Proc. Natl. Acad. Sci. U.S.A. 103, 9262-9267. doi:10.1073/pnas.0603371103.
21. Lai, E. C. (2004). Notch signaling: control of cell communication and cell fate. Development 131, 965-973. doi:10.1242/dev.01074.
22. Magni, M., Shammah, S., Schiro, R., Mellado, W., Dalla-Favera, R., and Gianni, A. M. (1996). Induction of cyclophosphamide-resistance by aldehyde-dehydrogenase gene transfer. Blood 87, 1097-1103.
23. Marcato, P., Dean, C. A., Giacomantonio, C. A., and Lee, P. W. (2011). Aldehyde dehydrogenase: its role as a cancer stem cell marker comes down to the specific isoform. Cell Cycle 10, 1378-1384. doi:10.4161/cc.10.9.15486.
24. Messerschmitt, P. J., Garcia, R. M., Abdul-Karim, F. W., Greenfield, E. M., and Getty, P. J. (2009). Osteosarcoma. J. Am. Acad. Orthop. Surg. 17, 515-527.
25. Meyers, P. A., and Gorlick, R. (1997). Osteosarcoma. Pediatr. Clin. North Am. 44, 973-989. doi:10.1016/S0031-3955(05)70540-X.
26. Meyers, P. A., Schwartz, C. L., Krailo, M., Kleinerman, E. S., Betcher, D., Bernstein, M. L., et al. (2005). Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate. J. Clin. Oncol. 23, 2004-2011. doi:10.1200/JCO.2005.06.031.
27. Meyers, P. A., Schwartz, C. L., Krailo, M. D., Healey, J. H., Bernstein, M. L., Betcher, D., et al. (2008). Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival-a report from the Children's Oncology Group. J. Clin. Oncol. 26, 633-638. doi:10.1200/JCO.2008.14.0095.
28. Miyamoto, Y., Maitra, A., Ghosh, B., Zechner, U., Argani, P., Iacobuzio-Donahue, C. A., et al. (2003). Notch mediates TGF alpha-induced changes in epithelial differentiation during pancreatic tumorigenesis. Cancer Cell 3, 565-576. doi:10.1016/S1535-6108(03)00140-5.
29. Mu, X., Isaac, C., Schott, T., Huard, J., and Weiss, K. (2012). Rapamycin inhibits ALDH activity, resistance to oxidative stress, and metastatic potential in murine osteosarcoma cells. Sarcoma 2013:480713. doi:10.1155/2013/480713.
30. Mu, X., Urso, M. L., Murray, K., Fu, F., and Li, Y. (2010). Relaxin regulates MMP expression and promotes satellite cell mobilization during muscle healing in both young and aged mice. Am. J. Pathol. 177, 2399-2410. doi:10.2353/ajpath.2010.091121.
31. Radtke, F., and Raj, K. (2003). The role of Notch in tumorigenesis: oncogene or tumour suppressor? Nat. Rev. Cancer 3, 756-767. doi:10.1038/nrc1186.
32. Russo, J. E., and Hilton, J. (1988). Characterization of cytosolic aldehyde dehydrogenase from cyclophosphamide resistant L1210 cells. Cancer Res. 48, 2963-2968.
33. van den Heuvel, S., and Dyson, N. J. (2008). Conserved functions of the pRB and E2F families. Nat. Rev. Mol. Cell Biol. 9, 713-724. doi:10.1038/nrm2469.
34. van Es, J. H., van Gijn, M. E., Riccio, O., van den Born, M., Vooijs, M., Begthel, H., et al. (2005). Notch/gamma-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells. Nature 435, 959-963. doi:10.1038/nature03659.
35. Wang, L. L. (2005). Biology of osteogenic sarcoma. Cancer J. 11, 294-305. doi:10.1097/00130404-200507000-00005.
36. Wang, Z., Li, Y., Banerjee, S., Kong, D., Ahmad, A., Nogueira, V., et al. (2010). Down-regulation of Notch-1 and Jagged-1 inhibits prostate cancer cell growth, migration and invasion, and induces apoptosis via inactivation of Akt, mTOR, and NF-kappaB signaling pathways. J. Cell. Biochem. 109, 726-736. doi:10.1002/jcb.22451.
37. Weiss, K. R., Cooper, G. M., Jadlowiec, J. A., Mcgough, R. L. III, and Huard, J. (2006). VEGF and BMP expression in mouse osteosarcoma cells. Clin. Orthop. Relat. Res. 450, 111-117. doi:10.1097/01.blo.0000229333.98781.56.
38. Weng, A. P., Ferrando, A. A., Lee, W., Morris, J. P. T., Silverman, L. B., Sanchez-Irizarry, C., et al. (2004). Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 306, 269-271. doi:10.1126/science.1102160.
39. Wicha, M. S., Liu, S., and Dontu, G. (2006). Cancer stem cells: an old idea-a paradigm shift. Cancer Res. 66, 1883-1890. doi:10.1158/0008-5472.CAN-05-3153 discussion 1895-1886, .
40. Witzenbichler, B., Asahara, T., Murohara, T., Silver, M., Spyridopoulos, I., Magner, M., et al. (1998). Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia. Am. J. Pathol. 153, 381-394. doi:10.1016/S0002-9440(10)65582-4.
41. Zhang, P., Yang, Y., Nolo, R., Zweidler-Mckay, P. A., and Hughes, D. P. (2010). Regulation of NOTCH signaling by reciprocal inhibition of HES1 and Deltex 1 and its role in osteosarcoma invasiveness. Oncogene 29, 2916-2926. doi:10.1038/onc.2010.62.
42. Zhang, P., Yang, Y., Zweidler-Mckay, P. A., and Hughes, D. P. (2008). Critical role of notch signaling in osteosarcoma invasion and metastasis. Clin. Cancer Res. 14, 2962-2969. doi:10.1158/1078-0432.CCR-07-1992.
43. Zhang, Z. G., Zhang, L., Jiang, Q., Zhang, R., Davies, K., Powers, C., et al. (2000). VEGF enhances angiogenesis and promotes blood-brain barrier leakage in the ischemic brain. J. Clin. Invest. 106, 829-838. doi:10.1172/JCI9369.